CoChat

Safety of Paracetamol in Osteoarthritis: What Does the Literature Say?

Open access

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Osteoarthritis (OA) is a major cause of pain and physical disability in adults, and an increasingly common disease given its associations with aging and a growing obese/overweight population. Paracetamol is widely recommended for analgesia at an early stage in the management of OA, and, although frequently prescribed, evidence suggests the efficacy of paracetamol for OA pain is low. Furthermore, there have been recent concerns over the safety profile of paracetamol, with reports of gastrointestinal, cardiovascular, hepatic and renal adverse events. This narrative review summarizes recent literature on the benefits and harms of paracetamol for OA pain. Data on long-term paracetamol safety are derived largely from observational evidence, and are difficult to interpret given the potential biases of such data. Nonetheless, a considerable degree of toxicity is associated with paracetamol use among the general population, especially at the upper end of standard analgesic doses. Paracetamol is linked to liver function abnormalities and there is evidence for liver failure associated with non-intentional paracetamol overdose. Safety data for paracetamol use in the older population (aged >65 years) are sparse; however, there is some evidence that frail elderly people may have impaired paracetamol clearance. Given that the analgesic benefit of paracetamol in OA joint pain is uncertain and potential safety issues have been raised, more careful consideration of its use is required.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40266-019-00658-9

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 42 references

Cited by

See all 101

Metadata

Authors
Conaghan, P. G., Arden, N., Avouac, B., Migliore, A., & Rizzoli, R.
Affiliations
  • University of Leeds (GB)
  • Southampton General Hospital (GB)
  • University of Liège (BE)
  • Fatebenefratelli Hospital (IT)
  • University of Geneva (CH)
Corresponding author
Conaghan, Philip G.
Venue
Drugs & Aging
Published
2019-04
Volume
36
Issue
S1
Pages
7-14
ISSN
  • 1170-229X (ISSN-L)
  • 1179-1969
OpenAlex
W2944358359
Cited by
101
References
42
Citations by year
2026: 12 · 2025: 9 · 2024: 13 · 2023: 10 · 2022: 19 · 2021: 21 · 2020: 11 · 2019: 5
FWCI
2.26
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • creativecommons.org/licenses/by-nc/4.0 (tdm)
Locations
  • Drugs & Aging (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by-nc)
Funders
  • National Institute for Health and Care Research
  • Leeds Biomedical Research Centre
Topics
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
paracetamol, osteoarthritis, drug safety, analgesia, adverse drug reactions, hepatotoxicity, liver failure, acetaminophen overdose, gastrointestinal toxicity, cardiotoxicity, nephrotoxicity, elderly patients, frail elderly, joint pain
MeSH terms
Acetaminophen, Aged, Dose-Response Relationship, Drug, Humans, Osteoarthritis, Analgesics, Non-Narcotic, Arthralgia, Chemical and Drug Induced Liver Injury, Pain Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Safety of Paracetamol in Osteoarthritis: What Does the Literature Say? https://app.cochat.ai/papers/10.1007/s40266-019-00658-9
The paper
Conaghan, P. G., Arden, N., Avouac, B., Migliore, A., & Rizzoli, R. (2019). Safety of Paracetamol in Osteoarthritis: What Does the Literature Say? Drugs & Aging. https://doi.org/10.1007/s40266-019-00658-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.